Prakash Raman
Prakash Raman is Chief Executive Officer at InduPro. He has previously held leadership and scientific roles at AstraZeneca, Flagship Pioneering, Millennium Pharmaceuticals, and Novartis.
Recent coverage
Front-page news, podcasts and videos about Prakash
InduPro raises $77M Series B, doses first patient in Phase 1 trial of IDP-001 targeting tumor protein pairs
InduPro raised $77 million in Series B financing and has dosed the first patient in a Phase 1 trial of IDP-001, an antibody-drug conjugate that uses the company’s ARRIS platform to target cancer cells by bringing two surface proteins together.
InduPro Raises $77M Series B Led by The Column Group and Doses First Patient in Phase 1 Trial of IDP-001
InduPro closed a $77 million Series B financing led by The Column Group and dosed the first patient in a Phase 1 trial of IDP-001, a bispecific antibody-drug conjugate targeting EGFR and a novel tumor-associated proximity antigen for advanced squamous NSCLC and other solid tumors.
Organizations
See all 8-
InduPro Chief Executive Officer 2024–present · current
-
Ribon Therapeutics President and CEO 2022–2024 · past
-
Flagship Pioneering Senior Partner, Chief Business Development Officer 2019–2022 · past
Education
-
University of Wisconsin-Madison Ph.D., Organic & Medicinal Chemistry · 1991–1997
-
Indian Institute of Technology, Bombay M.S., Organic Chemistry · 1986–1991
-
vivek vidyalaya 1982–1984
-
Kabwe Secondary School 1980–1982
